Lucid (LCID)

Search documents
LUCID ALERT: Bragar Eagel & Squire, P.C. is Investigating Lucid Group on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2024-11-21 02:00
NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Lucid Group (NASDAQ: LCID) on behalf of long-term stockholders following a class action complaint that was filed against Lucid on April 1, 2022 with a Class Period from November 15, 2021 to August 3, 2022. Our investigation concerns whether the board of directors of Lucid have breached their fiduciary duties to the company. The Lucid class-ac ...
Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test
Prnewswire· 2024-11-20 12:56
NEW YORK, Nov. 20, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it has submitted its complete clinical evidence package for its EsoGuard® Esophageal DNA Test in support of a Request for Reconsideration of Local Coverage Determination (LCD) L39256 "MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, an ...
Should you buy LCID stock as Lucid becomes ‘mostly immune' to EV credit cuts?
Finbold· 2024-11-19 14:12
After weeks of extended losses, electric vehicle manufacturer Lucid Motors (NASDAQ: LCID) is striving to stabilize its valuation above $2.The equity, currently valued at $2.14, ended the last trading session up 6.47%. However, on the weekly chart, LCID is down almost 8%.Ahead of trading on November 19, the stock is signaling an inability to sustain the previous session’s momentum, down 0.47% in the pre-market. LCID one-week stock price chart. Source: FinboldLCID share price needs to target the $3 resistance ...
Why Lucid stock price is soaring
Finbold· 2024-11-19 09:43
After experiencing a significant total fall in the last 30 days and even showing the dreaded death cross indicator in its chart, Lucid Motors (NASDAQ: LCID) stock suddenly entered a significant rally on Monday, November 18.Specifically, though the company is 16.08% down in the one-month chart and 7.75% down in the seven-day time frame, it rallied 6.47% during the last session to its latest closing price of $2.14.LCID stock 1-day price chart with the Tuesday pre-market. Source: GoogleThe very start of the Tu ...
BlackRock dumps over 2 million Lucid (LCID) shares
Finbold· 2024-11-18 15:36
The world’s largest asset manager, BlackRock (NYSE: BLK) holds stock in more than 5,000 businesses. The sheer scale of the investment giant’s dealings is tough to comprehend — but honing in on how the company treats specific businesses can serve as a worthwhile barometer.As one of the players at the forefront of ESG (environmental, social, and governance) investing, Blackrock’s focus on renewables has led it to invest in numerous ventures that are tackling the issue of climate change. One such company is Lu ...
Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Prnewswire· 2024-11-18 13:15
NEW YORK, Nov. 18, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that company management will present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York on Thursday, November 21, 2024 at 1:30 p.m. ET.Live and replay webcasts may be accessed on the investor relations section of the Company's website ...
Lucid set to become penny stock as death cross solidifies downtrend
Finbold· 2024-11-15 13:20
Lucid (NASDAQ: LCID) has become something of a posterchild for the troubles facing West-based electric vehicle (EV) makers that are not Tesla (NASDAQ: TSLA).Not only has LCID stock done little else than decline in 2024 and beyond, but technical analysis (TA) of the shares now signals an even greater downtrend to come.Specifically, on the evening of Thursday, November 14, Lucid formed its first death cross chart pattern since 2022. The death cross is a technical analysis signal that forms when the short-term ...
Where Will Lucid Be in 1 Year?
The Motley Fool· 2024-11-14 09:32
Lucid is stuck in first gear and struggling to get going.Like many other electric vehicle start-ups right now, Lucid Group (LCID 1.87%) is trying to find its footing in an increasingly competitive market. The company's impressive Air sedan has caught the automotive world's attention, but its stock has failed to impress investors.So, where is Lucid headed over the next year? I think the company is in for a bumpy ride and could face some of the same production and funding issues it's currently dealing with. H ...
Why Lucid Stock Soared Today
The Motley Fool· 2024-11-13 18:39
Shares of Lucid Group (LCID 3.50%) surged on Wednesday, hitting a hit of 8.9% in the early morning. The stock was trading 4.5% higher as of 12:30 p.m. ET.Investors in the electric vehicle (EV) stock seem to be shrugging off their disappointment with President-elect Donald Trump's choice of new Environmental Protection Agency (EPA) leader and shifting focus to things that could give Lucid a new lease of life.Lucid is hoping the police uses its Air sedanLucid stock fell yesterday as investors reacted to Trump ...
Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results
Prnewswire· 2024-11-13 13:01
EsoGuard® revenue up 20 percent sequentiallyClinical evidence package for Medicare coverage submission complete Direct contracting initiative expanded to multiple programs to drive near-term revenue growthConference call and webcast to be held today, November 13th at 8:30 AM ESTNEW YORK, Nov. 13, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" ...